Overview

A Retrospective Study of Anti-Vascular Endothelial Growth Factor (VEGF) Injections for Retinal Vein Occlusion or Diabetic Macular Edema

Status:
Completed
Trial end date:
2014-09-04
Target enrollment:
Participant gender:
Summary
This retrospective data review study will evaluate anti-VEGF injections for retinal vein occlusion (RVO) or diabetic macular edema (DME).
Details
Lead Sponsor:
Allergan
Treatments:
Bevacizumab
Endothelial Growth Factors